Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Missense mutations in DYT-TOR1A dystonia.

Iqbal Z, Koht J, Pihlstrøm L, Henriksen SP, Cappelletti C, Russel MB, Norberto de Souza O, Skogseid IM, Toft M.

Neurol Genet. 2019 Jun 6;5(4):e343. doi: 10.1212/NXG.0000000000000343. eCollection 2019 Aug. No abstract available. Erratum in: Neurol Genet. 2019 Aug 15;5(4):e350.

2.

Dopa-responsive dystonia.

Randby H, Salvador CL, Oppebøen M, Skogseid IM, Koht J.

Tidsskr Nor Laegeforen. 2018 Nov 26;138(19). doi: 10.4045/tidsskr.17.0595. Print 2018 Nov 27. Review. English, Norwegian.

3.

Multiple Microelectrode Recordings in STN-DBS Surgery for Parkinson's Disease: A Randomized Study.

Bjerknes S, Toft M, Konglund AE, Pham U, Waage TR, Pedersen L, Skjelland M, Haraldsen I, Andersson S, Dietrichs E, Skogseid IM.

Mov Disord Clin Pract. 2018 May 8;5(3):296-305. doi: 10.1002/mdc3.12621. eCollection 2018 May-Jun.

4.

Dystonia-deafness syndrome caused by ACTB p.Arg183Trp heterozygosity shows striatal dopaminergic dysfunction and response to pallidal stimulation.

Skogseid IM, Røsby O, Konglund A, Connelly JP, Nedregaard B, Jablonski GE, Kvernmo N, Stray-Pedersen A, Glover JC.

J Neurodev Disord. 2018 May 22;10(1):17. doi: 10.1186/s11689-018-9235-z.

5.

Self-Reported Executive Functioning in Everyday Life in Parkinson's Disease after Three Months of Subthalamic Deep Brain Stimulation.

Pham UH, Andersson S, Toft M, Pripp AH, Konglund AE, Dietrichs E, Malt UF, Skogseid IM, Haraldsen IR, Solbakk AK.

Parkinsons Dis. 2015;2015:461453. doi: 10.1155/2015/461453. Epub 2015 Jun 18.

6.

Practical guidance for CD management involving treatment of botulinum toxin: a consensus statement.

Albanese A, Abbruzzese G, Dressler D, Duzynski W, Khatkova S, Marti MJ, Mir P, Montecucco C, Moro E, Pinter M, Relja M, Roze E, Skogseid IM, Timerbaeva S, Tzoulis C.

J Neurol. 2015 Oct;262(10):2201-13. doi: 10.1007/s00415-015-7703-x. Epub 2015 Apr 1. Review.

7.

Personality changes after deep brain stimulation in Parkinson's disease.

Pham U, Solbakk AK, Skogseid IM, Toft M, Pripp AH, Konglund AE, Andersson S, Haraldsen IR, Aarsland D, Dietrichs E, Malt UF.

Parkinsons Dis. 2015;2015:490507. doi: 10.1155/2015/490507. Epub 2015 Jan 29.

8.

Pallidal neurostimulation in patients with medication-refractory cervical dystonia: a randomised, sham-controlled trial.

Volkmann J, Mueller J, Deuschl G, Kühn AA, Krauss JK, Poewe W, Timmermann L, Falk D, Kupsch A, Kivi A, Schneider GH, Schnitzler A, Südmeyer M, Voges J, Wolters A, Wittstock M, Müller JU, Hering S, Eisner W, Vesper J, Prokop T, Pinsker M, Schrader C, Kloss M, Kiening K, Boetzel K, Mehrkens J, Skogseid IM, Ramm-Pettersen J, Kemmler G, Bhatia KP, Vitek JL, Benecke R; DBS study group for dystonia.

Lancet Neurol. 2014 Sep;13(9):875-84. doi: 10.1016/S1474-4422(14)70143-7. Epub 2014 Aug 7.

PMID:
25127231
9.

Surgical site infections after deep brain stimulation surgery: frequency, characteristics and management in a 10-year period.

Bjerknes S, Skogseid IM, Sæhle T, Dietrichs E, Toft M.

PLoS One. 2014 Aug 14;9(8):e105288. doi: 10.1371/journal.pone.0105288. eCollection 2014.

10.

Long-term follow-up of thalamic deep brain stimulation for essential tremor - patient satisfaction and mortality.

Børretzen MN, Bjerknes S, Sæhle T, Skjelland M, Skogseid IM, Toft M, Dietrichs E.

BMC Neurol. 2014 Jun 5;14:120. doi: 10.1186/1471-2377-14-120.

11.

Dystonia--new advances in classification, genetics, pathophysiology and treatment.

Skogseid IM.

Acta Neurol Scand Suppl. 2014;(198):13-9. doi: 10.1111/ane.12231. Review.

PMID:
24588501
12.

Good outcome in patients with early dietary treatment of GLUT-1 deficiency syndrome: results from a retrospective Norwegian study.

Ramm-Pettersen A, Nakken KO, Skogseid IM, Randby H, Skei EB, Bindoff LA, Selmer KK.

Dev Med Child Neurol. 2013 May;55(5):440-7. doi: 10.1111/dmcn.12096. Epub 2013 Mar 1.

13.

A new rechargeable device for deep brain stimulation: a prospective patient satisfaction survey.

Timmermann L, Schüpbach M, Hertel F, Wolf E, Eleopra R, Franzini A, Servello D, Skogseid IM, Rumia J, Aliaga AS, Barbe MT, Pauls KA, Lin JP, Moro E, Lloyd A, Maarouf M.

Eur Neurol. 2013;69(4):193-9. doi: 10.1159/000342236. Epub 2013 Jan 10.

PMID:
23328107
14.

Pallidal deep brain stimulation in patients with primary generalised or segmental dystonia: 5-year follow-up of a randomised trial.

Volkmann J, Wolters A, Kupsch A, Müller J, Kühn AA, Schneider GH, Poewe W, Hering S, Eisner W, Müller JU, Deuschl G, Pinsker MO, Skogseid IM, Roeste GK, Krause M, Tronnier V, Schnitzler A, Voges J, Nikkhah G, Vesper J, Classen J, Naumann M, Benecke R; DBS study group for dystonia.

Lancet Neurol. 2012 Dec;11(12):1029-38. doi: 10.1016/S1474-4422(12)70257-0. Epub 2012 Nov 1.

PMID:
23123071
15.

Good long-term efficacy of pallidal stimulation in cervical dystonia: a prospective, observer-blinded study.

Skogseid IM, Ramm-Pettersen J, Volkmann J, Kerty E, Dietrichs E, Røste GK.

Eur J Neurol. 2012 Apr;19(4):610-5. doi: 10.1111/j.1468-1331.2011.03591.x. Epub 2011 Nov 25.

PMID:
22117556
16.

Long-term efficacy and mortality in Parkinson's disease patients treated with subthalamic stimulation.

Toft M, Lilleeng B, Ramm-Pettersen J, Skogseid IM, Gundersen V, Gerdts R, Pedersen L, Skjelland M, Røste GK, Dietrichs E.

Mov Disord. 2011 Aug 15;26(10):1931-4. doi: 10.1002/mds.23817. Epub 2011 Jun 8.

PMID:
21656853
17.

[Cervical dystonia--diagnosis and treatment].

Skogseid IM.

Tidsskr Nor Laegeforen. 2008 Oct 9;128(19):2202-5. Review. Norwegian.

18.

[Treatment of movement disorders with deep brain stimulation].

Toft M, Lilleeng B, Ramm-Pettersen J, Røste GK, Pedersen L, Skogseid IM, Dietrichs E.

Tidsskr Nor Laegeforen. 2008 Sep 11;128(17):1972-6. Review. Norwegian.

19.

Pallidal deep brain stimulation is effective, and improves quality of life in primary segmental and generalized dystonia.

Skogseid IM.

Acta Neurol Scand Suppl. 2008;188:51-5. doi: 10.1111/j.1600-0404.2008.01032.x. Review.

PMID:
18439222
20.

Pallidal deep brain stimulation improves quality of life in segmental and generalized dystonia: results from a prospective, randomized sham-controlled trial.

Mueller J, Skogseid IM, Benecke R, Kupsch A, Trottenberg T, Poewe W, Schneider GH, Eisner W, Wolters A, Müller JU, Deuschl G, Pinsker MO, Roeste GK, Vollmer-Haase J, Brentrup A, Krause M, Tronnier V, Schnitzler A, Voges J, Nikkhah G, Vesper J, Naumann M, Volkmann J; Deep-Brain Stimulation for Dystonia Study Group.

Mov Disord. 2008 Jan;23(1):131-4.

PMID:
17973330
21.

Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia.

Skogseid IM, Malt UF, Røislien J, Kerty E.

Eur J Neurol. 2007 Oct;14(10):1129-37. Epub 2007 Aug 15.

PMID:
17708754
22.

Pallidal deep-brain stimulation in primary generalized or segmental dystonia.

Kupsch A, Benecke R, Müller J, Trottenberg T, Schneider GH, Poewe W, Eisner W, Wolters A, Müller JU, Deuschl G, Pinsker MO, Skogseid IM, Roeste GK, Vollmer-Haase J, Brentrup A, Krause M, Tronnier V, Schnitzler A, Voges J, Nikkhah G, Vesper J, Naumann M, Volkmann J; Deep-Brain Stimulation for Dystonia Study Group.

N Engl J Med. 2006 Nov 9;355(19):1978-90.

23.

Long-term botulinum toxin treatment increases employment rate in patients with cervical dystonia.

Skogseid IM, Røislien J, Claussen B, Kerty E.

Mov Disord. 2005 Dec;20(12):1604-9.

PMID:
16114026
24.
25.

[Usefulness of SPECT and MRI in the diagnosis of atypical parkinsonism].

Skogseid IM, Gerdts R, Nyberg-Hansen R, Rootwelt K, Bakke SJ.

Tidsskr Nor Laegeforen. 2001 Nov 30;121(29):3399-403. Norwegian.

26.

[Intracranial venous thrombosis].

Skogseid IM, Wester K, Moen G.

Tidsskr Nor Laegeforen. 1997 Feb 20;117(5):692-8. Norwegian.

PMID:
9102963
27.

Increased serum creatine kinase BB and neuron specific enolase following head injury indicates brain damage.

Skogseid IM, Nordby HK, Urdal P, Paus E, Lilleaas F.

Acta Neurochir (Wien). 1992;115(3-4):106-11.

PMID:
1605077

Supplemental Content

Loading ...
Support Center